Skip to main content

Who Should Not Take a GLP-1 Medication?

By ElliotMeds · Updated November 4, 2026 · 2 min read

Short answer: semaglutide and tirzepatide are not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, for people with type 1 diabetes, or during pregnancy. Several other conditions need a clinician's review before treatment.

This article is educational and is not medical advice. Whether any treatment is appropriate for you is decided by a licensed clinician after reviewing your health history.

Who should not take semaglutide or tirzepatide?

Per the FDA-approved prescribing information (Wegovy, Zepbound), these medications should not be used by people with:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN2)
  • A prior serious allergic reaction to the medication

They are also not appropriate for type 1 diabetes or diabetic ketoacidosis, and are not recommended during pregnancy — they are generally stopped before a planned pregnancy.

What conditions need a clinician's review first?

These don't automatically rule out treatment, but they can change whether it's appropriate or when it can safely begin:

  • History of pancreatitis or gallbladder disease
  • Gastroparesis or another condition that slows stomach emptying
  • A current or past eating disorder
  • Diabetic retinopathy
  • Kidney disease
  • Taking insulin or a sulfonylurea (risk of low blood sugar)
  • Breastfeeding
  • A surgery or procedure requiring anesthesia in the next eight weeks

How does ElliotMeds screen for these?

The ElliotMeds medical intake asks about each of the conditions above, plus your full medication list. A licensed U.S. clinician reviews your answers and decides whether treatment is appropriate, asks for more information, or declines. If you're not approved, you receive a full refund.

Learn more

Sources

Every program includes a clinician chart review. When prescribed, treatments are filled by a licensed U.S. pharmacy.

Important note

Some treatments may involve compounded medications when prescribed by a clinician. Compounded medications are not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality before marketing. A licensed clinician determines whether a treatment is appropriate based on the information provided.